🇺🇸 FDA
Patent

US 9549995

Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy

granted A61KA61K31/70A61K31/7048

Quick answer

US patent 9549995 (Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy) held by The Board of Regents of the University of Texas System expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/70, A61K31/7048, A61K45/06, A61K49/0002